Health product recall

Taro-Zoledronic Acid (2020-03-30)

Starting date:
March 30, 2020
Type of communication:
Drug Recall
Subcategory:
Drugs
Hazard classification:
Type I
Source of recall:
Health Canada
Issue:
Product Safety
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-72683



Last updated: 2020-04-02

Summary

  • Product:
    Taro-Zoledronic Acid  5 mg/100 mL solution

Reason

The recall lots may contain particulate matter.

Depth of distribution

End users

Affected products

Taro-Zoledronic Acid  5 mg/100 mL solution

DIN, NPN, DIN-HIM

DIN 02415100

Dosage form

Solution

Strength

Zoledronic acid monohydrate 5 mg/100 mL

Lot or serial number

JKT1520A, JKT1580A, JKT1581A, JKT1642A, JKT1643A

Companies

Recalling Firm

Taro Pharmaceuticals Inc.

130 East Drive

Brampton

L6T 1C1

Ontario

CANADA

Marketing Authorization Holder

Taro Pharmaceuticals Inc.

130 East Drive

Brampton

L6T 1C1

Ontario

CANADA



Certain Lots of Taro-Zoledronic acid injection drug, used for osteoporosis and Paget's disease, recalled due to potential presence of particulate matter

2020-03-31 | Health products

Advisory


Report a problem or mistake on this page
What was wrong?

If you want to receive a follow-up reply, please include your name and e-mail address.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Date modified: